TT Capital and MSD invest in Clinithink

The fresh capital will enable Clinithink to undertake an international expansion strategy and broaden its range of services.

In a statement, the investors said the primary driver behind the investment was the growing global market for products that can provide efficiency in reviewing clinical documents.

Previous funding
Finance Wales and US-based venture house Vanguard Atlantic took part in a two-part, multi-million-dollar series-A funding round for Clinithink in 2012.

Company
Founded in 2009 and dual-headquartered in Cardiff and Atlanta, Clinithink is an analytics company that focuses on data analysis and mapping technology for the healthcare sector. The platform uses artificial intelligence to read and interpret clinical documents for the purpose of disease diagnosis, as well as drug and therapy development.

People
TT Capital Partners – Conor Green (partner).
Global Health Innovation Fund – Prem Tumkosit (investment principal).
Clinithink – Chris Tackaberry (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• UK / Ireland
• Technology
• United Kingdom
• Venture